Ecotoxicological evalution of tuberculostatic medicines: Predicted Environmental Concentration and biological effects in Daphnia similis and Echinometra lucunter.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/14825 |
Resumo: | The increase in the production of pharmaceutical products has been gradually increasing and, consequently, the residues of these products inappropriately in the aquatic environment as well. In this context, the scarcity of ecotoxicological studies on drugs of the tuberculostatic class in the aquatic environment is highlighted. Thus, the present study aimed to evaluate the presence of tuberculostatic drugs used as a standardized scheme by the Brazilian Ministry of Health for the treatment of tuberculosis (Rifampicin, Isoniazid, Pyrazinamide and Etambutol), by calculating the predicted environmental concentration (PEC) in surface waters of the municipality from Cubatão (São Paulo, Brazil). In addition, adverse biological effects on the test organisms Daphnia similis and Echinometra lucunter for the drugs Isoniazid and Pyrazinamide were evaluated. The PEC values were calculated among the four tuberculostatic drugs according to the guideline of the European Medicines Agency (EMEA) (CHMP, 2006). Afterwards, toxicity tests were performed on D. similis and E. lucunter according to Brazilian Association of Technical Standards ABNT NBR 12713:2016 e ABNT NBR 15350:2012, respectively. PEC values for all four tuberculostatic drugs included in the present study showed values that exceeded the limit considered by the EMEA of 0.01 µg.L-1. For the toxicity test with D. similis, the drugs Isoniazid and Pyrazinamide presented EC50 values of 69.97 mg.L-1 and 44.49 mg.L-1, respectively, being classified as “harmful” according to the Directive of the European Economic Community (EEC) 93/67 / EEC. As for the toxicity test with E. lucunter, the drugs Isoniazid and Pyrazinamide showed IC50 values of 23.66 mg.L-1 and 17.21 mg.L-1, respectively, results that are also considered “harmful” according to with Directive 93/67 / EEC. The results of this research may serve as subsidies to new legislation and the creation of government programs that seek solutions promoting reduction and even the elimination of pharmaceuticals in the aquatic environment. |
id |
UNIFEI_ed09d9ed0947e7f74fb38f82a334d2c6 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/14825 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Ecotoxicological evalution of tuberculostatic medicines: Predicted Environmental Concentration and biological effects in Daphnia similis and Echinometra lucunter.Evaluacion ecotoxicologica de medicamentos tuberculostaticos: Concentraciones Ambientales Estimadas y efectos biológicos em Daphnia similis y Echinometra lucunter.Avaliação ecotoxicológica de medicamentos tuberculostáticos: Concentrações Ambientais Estimadas e efeitos biológicos em Daphnia similis e Echinometra lucunter.IsoniazidaPirazinamidaFármacos no meio ambienteConcentração Ambiental EstimadaEcotoxicologia. IsoniazidPyrazinamidePharmaceuticals in the environmentPredicted Environmental ConcentrationEcotoxicology.IsoniazidaPirazinamidaDrogas en el medio ambienteConcentración ambiental estimadaEcotoxicología.The increase in the production of pharmaceutical products has been gradually increasing and, consequently, the residues of these products inappropriately in the aquatic environment as well. In this context, the scarcity of ecotoxicological studies on drugs of the tuberculostatic class in the aquatic environment is highlighted. Thus, the present study aimed to evaluate the presence of tuberculostatic drugs used as a standardized scheme by the Brazilian Ministry of Health for the treatment of tuberculosis (Rifampicin, Isoniazid, Pyrazinamide and Etambutol), by calculating the predicted environmental concentration (PEC) in surface waters of the municipality from Cubatão (São Paulo, Brazil). In addition, adverse biological effects on the test organisms Daphnia similis and Echinometra lucunter for the drugs Isoniazid and Pyrazinamide were evaluated. The PEC values were calculated among the four tuberculostatic drugs according to the guideline of the European Medicines Agency (EMEA) (CHMP, 2006). Afterwards, toxicity tests were performed on D. similis and E. lucunter according to Brazilian Association of Technical Standards ABNT NBR 12713:2016 e ABNT NBR 15350:2012, respectively. PEC values for all four tuberculostatic drugs included in the present study showed values that exceeded the limit considered by the EMEA of 0.01 µg.L-1. For the toxicity test with D. similis, the drugs Isoniazid and Pyrazinamide presented EC50 values of 69.97 mg.L-1 and 44.49 mg.L-1, respectively, being classified as “harmful” according to the Directive of the European Economic Community (EEC) 93/67 / EEC. As for the toxicity test with E. lucunter, the drugs Isoniazid and Pyrazinamide showed IC50 values of 23.66 mg.L-1 and 17.21 mg.L-1, respectively, results that are also considered “harmful” according to with Directive 93/67 / EEC. The results of this research may serve as subsidies to new legislation and the creation of government programs that seek solutions promoting reduction and even the elimination of pharmaceuticals in the aquatic environment.Con el tiempo, el crecimiento en la producción de productos farmacéuticos ha ido aumentando gradualmente y, en consecuencia, los residuos de estos productos de manera inapropiada también en el medio acuático. En este contexto, se destaca la escasez de estudios ecotoxicológicos sobre fármacos de la clase tuberculostática en el medio acuático. Así, el presente estudio tuvo como objetivo evaluar la presencia de fármacos tuberculostáticos utilizados como esquema estandarizado por el Ministerio de Salud de Brasil para el tratamiento de la tuberculosis (Rifampicina, Isoniazida, Pirazinamida y Etambutol), mediante el cálculo de la Concentración Ambiental Estimada (CAE) en aguas superficiales del municipio de Cubatão (São Paulo, Brasil). Además, se evaluaron los efectos biológicos adversos sobre los organismos de prueba Daphnia similis y Echinometra lucunter para los fármacos Isoniazida y Pirazinamida. CAE se calcularon entre los cuatro fármacos tuberculostáticos de acuerdo con las directrices de la Agencia Europea de Medicamentos (EMEA) (CHMP, 2006). Posteriormente, se realizaron pruebas de toxicidad en D. similis y E. lucunter según la Asociación Brasileña de Normas Técnicas (ABNT). Los resultados de las CAEs para todos los fármacos tuberculostáticos incluidos en el presente estudio mostraron valores superiores al límite considerado por la EMEA de 0,01 µg.L-1. Para el ensayo de toxicidad con D. similis, los fármacos Isoniazida y Pirazinamida tuvieron valores de CE50 de 69,97 mg.L-1 y 44,49 mg.L-1, respectivamente, siendo clasificados como “nocivos” según la Directiva de la Economía Europea. Comunidad (CEE) 93/67 / CEE. En cuanto al ensayo de toxicidad con E. lucunter, los medicamentos Isoniazida y Pirazinamida mostraron valores de IC50 de 23,66 mg.L-1 y 17,21 mg.L-1, respectivamente, resultados que también se consideran “nocivos” según la Directiva 93/67/ CEE. Los resultados de esta investigación pueden servir como subsidios a la nueva legislación y también a la creación de programas gubernamentales que busquen soluciones que promuevan la reducción e incluso la eliminación de las drogas en el medio acuático.Com o passar do tempo, o crescimento da produção de produtos farmacêuticos vem aumentando gradativamente e consequentemente, os resíduos destes produtos de forma inadequada no ambiente aquático também. Neste contexto, destaca-se a escassez de estudos ecotoxicológicos sobre os medicamentos da classe dos tuberculostáticos no meio aquático. Sendo assim, o presente estudo teve como objetivo avaliar a presença dos fármacos tuberculostáticos utilizados como esquema padronizado pelo Ministério da Saúde para o tratamento de tuberculose (Rifampicina, Isoniazida, Pirazinamida e Etambutol) em águas superficiais do município de Cubatão (São Paulo, Brasil), através do cálculo da concentração ambiental estimada (CAE). Adicionalmente, foram avaliados os efeitos biológicos adversos nos organismos-testes Daphnia similis e Echinometra lucunter para os fármacos Isoniazida e Pirazinamida. As concentrações ambientais estimadas foram calculadas para os quatro fármacos tuberculostáticos de acordo com a diretriz da Agência Europeia de Medicamentos (EMEA) (CHMP, 2006). Após, foram realizados ensaios de toxicidade em D. similis e E. lucunter de acordo com as normas ABNT NBR 12713:2016 e ABNT NBR 15350:2012, respectivamente. Os resultados das CAE para todos os fármacos tuberculostáticos incluídos neste estudo apresentaram valores superiores ao limite considerado pela EMEA de 0,01 µg.L-1. Para o ensaio de toxicidade com D. similis, os fármacos Isoniazida e Pirazinamida apresentaram valores de CE50 respectivamente 69,97 mg.L-1 e 44,49 mg.L-1 sendo estes classificados como “nocivos” de acordo com a Diretiva da Comunidade Econômica Europeia (CEE) 93/67/CEE. Já para o ensaio de toxicidade com o organismo-teste Echinometra lucunter, os fármacos Isoniazida e Pirazinamida apresentaram valores de CI50 23,66 mg.L-1 e 17,21 mg.L-1, respectivamente, resultados que os também como “nocivos” de acordo com a Diretiva 93/67/CEE. Os resultados desta pesquisa poderão servir como subsídios a novas legislações e a criação de programas governamentais que buscam soluções promovendo redução e até mesmo a eliminação de fármacos no ambiente aquático.Research, Society and Development2021-05-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1482510.33448/rsd-v10i5.14825Research, Society and Development; Vol. 10 No. 5; e42310514825Research, Society and Development; Vol. 10 Núm. 5; e42310514825Research, Society and Development; v. 10 n. 5; e423105148252525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/14825/13555Copyright (c) 2021 Monike Silva de Freitas; Walber Toma; Fábio Hermes Pusceddu; Luciana Lopes Guimarãeshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFreitas, Monike Silva de Toma, WalberPusceddu, Fábio Hermes Guimarães, Luciana Lopes 2021-05-17T18:20:49Zoai:ojs.pkp.sfu.ca:article/14825Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:35:49.469286Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Ecotoxicological evalution of tuberculostatic medicines: Predicted Environmental Concentration and biological effects in Daphnia similis and Echinometra lucunter. Evaluacion ecotoxicologica de medicamentos tuberculostaticos: Concentraciones Ambientales Estimadas y efectos biológicos em Daphnia similis y Echinometra lucunter. Avaliação ecotoxicológica de medicamentos tuberculostáticos: Concentrações Ambientais Estimadas e efeitos biológicos em Daphnia similis e Echinometra lucunter. |
title |
Ecotoxicological evalution of tuberculostatic medicines: Predicted Environmental Concentration and biological effects in Daphnia similis and Echinometra lucunter. |
spellingShingle |
Ecotoxicological evalution of tuberculostatic medicines: Predicted Environmental Concentration and biological effects in Daphnia similis and Echinometra lucunter. Freitas, Monike Silva de Isoniazida Pirazinamida Fármacos no meio ambiente Concentração Ambiental Estimada Ecotoxicologia. Isoniazid Pyrazinamide Pharmaceuticals in the environment Predicted Environmental Concentration Ecotoxicology. Isoniazida Pirazinamida Drogas en el medio ambiente Concentración ambiental estimada Ecotoxicología. |
title_short |
Ecotoxicological evalution of tuberculostatic medicines: Predicted Environmental Concentration and biological effects in Daphnia similis and Echinometra lucunter. |
title_full |
Ecotoxicological evalution of tuberculostatic medicines: Predicted Environmental Concentration and biological effects in Daphnia similis and Echinometra lucunter. |
title_fullStr |
Ecotoxicological evalution of tuberculostatic medicines: Predicted Environmental Concentration and biological effects in Daphnia similis and Echinometra lucunter. |
title_full_unstemmed |
Ecotoxicological evalution of tuberculostatic medicines: Predicted Environmental Concentration and biological effects in Daphnia similis and Echinometra lucunter. |
title_sort |
Ecotoxicological evalution of tuberculostatic medicines: Predicted Environmental Concentration and biological effects in Daphnia similis and Echinometra lucunter. |
author |
Freitas, Monike Silva de |
author_facet |
Freitas, Monike Silva de Toma, Walber Pusceddu, Fábio Hermes Guimarães, Luciana Lopes |
author_role |
author |
author2 |
Toma, Walber Pusceddu, Fábio Hermes Guimarães, Luciana Lopes |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Freitas, Monike Silva de Toma, Walber Pusceddu, Fábio Hermes Guimarães, Luciana Lopes |
dc.subject.por.fl_str_mv |
Isoniazida Pirazinamida Fármacos no meio ambiente Concentração Ambiental Estimada Ecotoxicologia. Isoniazid Pyrazinamide Pharmaceuticals in the environment Predicted Environmental Concentration Ecotoxicology. Isoniazida Pirazinamida Drogas en el medio ambiente Concentración ambiental estimada Ecotoxicología. |
topic |
Isoniazida Pirazinamida Fármacos no meio ambiente Concentração Ambiental Estimada Ecotoxicologia. Isoniazid Pyrazinamide Pharmaceuticals in the environment Predicted Environmental Concentration Ecotoxicology. Isoniazida Pirazinamida Drogas en el medio ambiente Concentración ambiental estimada Ecotoxicología. |
description |
The increase in the production of pharmaceutical products has been gradually increasing and, consequently, the residues of these products inappropriately in the aquatic environment as well. In this context, the scarcity of ecotoxicological studies on drugs of the tuberculostatic class in the aquatic environment is highlighted. Thus, the present study aimed to evaluate the presence of tuberculostatic drugs used as a standardized scheme by the Brazilian Ministry of Health for the treatment of tuberculosis (Rifampicin, Isoniazid, Pyrazinamide and Etambutol), by calculating the predicted environmental concentration (PEC) in surface waters of the municipality from Cubatão (São Paulo, Brazil). In addition, adverse biological effects on the test organisms Daphnia similis and Echinometra lucunter for the drugs Isoniazid and Pyrazinamide were evaluated. The PEC values were calculated among the four tuberculostatic drugs according to the guideline of the European Medicines Agency (EMEA) (CHMP, 2006). Afterwards, toxicity tests were performed on D. similis and E. lucunter according to Brazilian Association of Technical Standards ABNT NBR 12713:2016 e ABNT NBR 15350:2012, respectively. PEC values for all four tuberculostatic drugs included in the present study showed values that exceeded the limit considered by the EMEA of 0.01 µg.L-1. For the toxicity test with D. similis, the drugs Isoniazid and Pyrazinamide presented EC50 values of 69.97 mg.L-1 and 44.49 mg.L-1, respectively, being classified as “harmful” according to the Directive of the European Economic Community (EEC) 93/67 / EEC. As for the toxicity test with E. lucunter, the drugs Isoniazid and Pyrazinamide showed IC50 values of 23.66 mg.L-1 and 17.21 mg.L-1, respectively, results that are also considered “harmful” according to with Directive 93/67 / EEC. The results of this research may serve as subsidies to new legislation and the creation of government programs that seek solutions promoting reduction and even the elimination of pharmaceuticals in the aquatic environment. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-05-12 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/14825 10.33448/rsd-v10i5.14825 |
url |
https://rsdjournal.org/index.php/rsd/article/view/14825 |
identifier_str_mv |
10.33448/rsd-v10i5.14825 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/14825/13555 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 5; e42310514825 Research, Society and Development; Vol. 10 Núm. 5; e42310514825 Research, Society and Development; v. 10 n. 5; e42310514825 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052676079353856 |